Skip to main content
. 2020 Jul 17;11:657. doi: 10.3389/fgene.2020.00657

TABLE 2.

Example of Information to be disclosed during the Consent Process for Embryo Donor(s) (Kington, 2016).

Information to be disclosed during the consent process:
• Donation is voluntary and will not affect any healthcare service provided.
• The embryos will be used to derive ESCs for research.
• What will happen to the embryos during the derivation of ESCs for research.
• HESCs derived from the embryos might be kept for many years.
• Donation is made without any restriction or direction regarding the individual(s) who may receive medical benefit from the use of the ESCs, such as who may be the recipient(s) of cell transplants.
• The research is not intended to provide direct medical benefit to the donor(s).
• The results of research using the ESCs may have commercial potential; however, the donor(s) will not receive financial or any other benefits from any such commercial development.
• What potentially identifying information about the donor(s) will be available to researchers.
• Donor(s) retain the right to withdraw consent for the donation of the embryo until the embryos are actually used to derive ESCs or until information which could link the identity of the donor(s) to the embryo are no longer retained, if applicable.
• No payments, cash or in kind, will be offered for the donated embryos.